Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
03/2002
03/28/2002CA2416136A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
03/28/2002CA2357901A1 Combination treatment for depression and anxiety
03/27/2002EP1191036A2 Methods and compositions for diagnosing and treating disorders involving angiogenesis
03/27/2002EP1191027A1 Fused ring system containing indole as M4 selective aza-anthracene muscarinic receptor antagonists
03/27/2002EP1191022A1 Novel dihydropyridine derivative
03/27/2002EP1191021A1 Dihydropyridine derivative
03/27/2002EP1190716A1 The leaves of cajanus cajan(l.) millsp and extract, formulation and uses thereof
03/27/2002EP1190249A2 Compounds and methods to enhance raav transduction
03/27/2002EP1190086A2 Genetic modification of male germ cells for generation of transgenic species and genetic therapies
03/27/2002EP1190074A1 Recombinant anti-cd40 antibody and uses thereof
03/27/2002EP1190072A2 22012, a novel human carboxypeptidase
03/27/2002EP1190065A2 Atp binding cassette transporter protein abc1 polypeptides
03/27/2002EP1190059A1 Sgip peptides
03/27/2002EP1190057A1 Cloning and expression of a novel 5-ht4 receptor
03/27/2002EP1190053A2 Mammalian calcium channels and related probes, cell lines and methods
03/27/2002EP1190052A1 16405 receptor, a g-protein coupled receptor
03/27/2002EP1190051A2 Human transport proteins
03/27/2002EP1190049A1 Spliceosome protein and its use
03/27/2002EP1189942A1 Somatostatin agonists
03/27/2002EP1189941A1 Neuromedin b and somatostatin receptor agonists
03/27/2002EP1189931A2 Peptide compounds that bind her2
03/27/2002EP1189922A1 Steroid derivatives
03/27/2002EP1189905A1 Substituted heterocycle fused gamma-carbolines
03/27/2002EP1189904A1 Substituted heterocycle fused gamma-carbolines
03/27/2002EP1189900A1 Heterocyclic aminopyrrolidine derivatives as melatonergic agents
03/27/2002EP1189896A1 Substituted 5-oxo-5,6,7,8-tetrahydro-4h-1-benzopyrans and benzothiopyrans and the use thereof as potentiators of ampa
03/27/2002EP1189895A1 Thiazole and oxazole derivatives and their pharmaceutical use
03/27/2002EP1189889A1 Compositions and methods for inhibiting cell death
03/27/2002EP1189888A1 HETEROSUBSTITUTED PYRIDINE DERIVATIVES AS $i(PDE 4) INHIBITORS
03/27/2002EP1189886A1 Ethanesulfonyl-piperidine derivatives
03/27/2002EP1189881A1 Propanoic acid derivatives that inhibit the binding of integrins to their receptors
03/27/2002EP1189873A1 Excitatory amino acid receptor modulators
03/27/2002EP1189662A1 Combination for treating weight gain associated with antipsychotic use comprising an atypical antipsychotic and an h2 antagonist
03/27/2002EP1189640A1 Pharmaceutical complex
03/27/2002EP1189631A1 Neurodegenerative disorder related gene
03/27/2002EP1189628A1 Combination of tumor necrosis factor (tnf) antagonists and cox-2 inhibitors for the treatment of inflammation
03/27/2002EP1189617A1 Novel pharmaceutical combination with analgesic action containing paracetamol and buspirone
03/27/2002EP1189616A2 S-hydroxynefazodone
03/27/2002EP1189614A2 Solid preparations containing paroxetine
03/27/2002EP1189613A1 Method for the treatment of neurological or neuropsychiatric disorders
03/27/2002EP1189612A1 Vla-4 inhibitor compounds
03/27/2002EP1189609A1 Cxcr-4 receptor antagonists - thrombopoietin mimetics
03/27/2002EP1189608A1 Levodopa/carbidopa/entacapone pharmaceutical preparation
03/27/2002EP1189606A2 Novel iron chelators and pharmaceutical compositions comprising iron chelators for the treatment of neurodegenerative disorders
03/27/2002EP1189605A2 High molecular weight primary aliphatic alcohols obtained from beeswax and pharmaceutical use thereof
03/27/2002EP1189604A2 Zinc ionophores as anti-apoptotic agents
03/27/2002EP1189602A1 Morphine sulphate microgranules, method for preparing same and compositions containing same
03/27/2002EP1189598A1 A method for the improvement of transport across adaptable semi-permeable barriers
03/27/2002EP1189596A1 Pharmaceutical composition for nasally administering water-soluble active substances
03/27/2002EP1189583A1 Indole derivatives
03/27/2002EP1064284B1 Hypnotic beta-carboline derivatives, process for their preparation and their use as medicinal products
03/27/2002EP1007534A4 Bh3 interacting domain death agonist
03/27/2002EP0946562B1 PYRROLO[3,4-d]PYRIMIDINONE DERIVATIVES AND THEIR USE AS IMMUNOSUPPRESSANTS
03/27/2002EP0946503B1 Nitromethylthiobenzene derivatives as inhibitors of aldose reductase
03/27/2002EP0932597B1 Use of gamma-hydroxybutyric acid amides in the treatment of drug addiction and in particular of alcoholism
03/27/2002EP0873336B1 Antagonists of gonadotropin releasing hormone
03/27/2002EP0843661B1 (1s,2s)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanolmethanesulfonate trihydrate
03/27/2002EP0799056B1 Use of a nk-1 receptor antagonist and an opioid analgesic
03/27/2002EP0790996B1 Pyridazinoquinoline compounds
03/27/2002EP0786998B1 Use of r-(z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo 2.2.2] oct-3-yl) acetonitrile to reduce amyloid beta a4 formation in alzheimer's disease
03/27/2002EP0782574B1 Bicyclic carboxamides as 5-ht1a receptors ligands
03/27/2002EP0651746B1 Drugs that enhance synaptic responses mediated by ampa receptors
03/27/2002EP0610336B1 Treatment of neurological conditions by an interleukin-1 inhibiting compound
03/27/2002CN1342202A Soluble receptor BR43X2 and methods for using them for therapy
03/27/2002CN1342171A Process for production of multiple cross-linked hyaluronic acid derivatives
03/27/2002CN1342166A GLP-1 analogues
03/27/2002CN1342165A Neurotrophic growth factor
03/27/2002CN1342162A Substituted 2-acyl-3-(heteroaryl)-imidazo [1,2-a] pyrimidines, and related pharmaceutical compoistions and methods
03/27/2002CN1342161A Tricyclic inhibitors of poly(ADP-ribose) polymerases
03/27/2002CN1342152A N-substituted imide derivatives with serotonergic activity
03/27/2002CN1342149A Prostaglandin endoperoxide H synthase biosynthesis inhibitors
03/27/2002CN1342082A Use of tianeptin in production of medicaments to treat neurodegenerative pathologies
03/27/2002CN1342080A Use of 5-HT5-ligands in treatment of neurodegenerative and neuropsychiatric disturbances
03/27/2002CN1342079A Treatment and prevention of reactive oxygen metablite-mediated cellular damage
03/27/2002CN1342074A Antidepressant heterocyclic compounds
03/27/2002CN1342073A Antioxidant compositions and methods for companion animals
03/27/2002CN1342070A Binding partners for 5-HT5 receptors for treatment of migraine
03/27/2002CN1341662A Scorpion pain-stopping anti-tumor Val-Arg-Gly peptide and its preparation method
03/27/2002CN1341599A Novel benzodiazine compound, its preparation method and medicine composition containing them
03/27/2002CN1341449A Perlingual sweets for relieving acute alcoholism and its preparation method
03/27/2002CN1341434A Medicine and health-care product formed from ganglioside and ginkgo leaf extract and their application
03/27/2002CN1341432A Brain-tonifying intelligence-raising granules
03/27/2002CN1341420A Medicine formed from ganglioside and erigeron breviscapus extract and health-care product and their application
03/27/2002CN1081635C Substituted pyrrolidine-3-Yl-alkyl-piperidines
03/27/2002CN1081631C N-methyl-N[(1S)-1-phenyl-2-(2S)-3-hydroxypyrrolidin-1-yl)ethyl]-2,2-diphenylacetamide
03/27/2002CN1081625C 1-aryl-2-acylamino-ethane compounds and their use as meurokinin especially neurokinin 1 antagonists
03/27/2002CN1081460C Use of medicine for reducing tissue damage associated with non-cardiac ischemia by aldose reductase inhibitor
03/26/2002US6362371 β2- adrenergic receptor agonists
03/26/2002US6362319 Glial cell line-derived neurotrophic factor
03/26/2002US6362316 Human metabotropic glutamate receptor subtype mGluR6 protein
03/26/2002US6362234 Water-soluble prodrugs of propofol for treatment of migrane
03/26/2002US6362230 Alzheimer's disease
03/26/2002US6362227 Methods for the treatment of tinnitus and other disorders using R(−)ketoptofen
03/26/2002US6362222 Topical applying
03/26/2002US6362211 Polycyclic indanylimidazoles with alpha2 adrenergic activity
03/26/2002US6362209 Heterocyclic aromatic oxazole compounds and use thereof
03/26/2002US6362203 4-hydroxy-4-phenylpiperidine derivatives and pharmaceuticals containing the same
03/26/2002US6362199 Central nervous system disorders; psychological disorders
03/26/2002US6362196 Method to treat pain utilizing benzimidazole NMDA/NR2B antagonists
03/26/2002US6362195 Inhibitor of nitric oxide synthase; central nervous system disorders
1 ... 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 ... 1833